Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genzyme, a Sanofi Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
life expectancy of at least 12 months,
patients have received hemodialysis three times per week for 3 months or longer,
patients maintained on sevelamer in a daily dose of ≤ 9,600 mg as their only phosphate binder with serum phosphorus concentrations at the last two measurements between 3.0 and 6.5 mg/dL (0.97 and 2.10 mmol/L).
You may not be if
active bowel obstruction,
dysphagia,
swallowing disorders,
severe gastrointestinal motility disorders,
active ethanol or drug abuse (excluding tobacco),
need for antidysrhythmic or antiseizure medications used to control these conditions,
poorly controlled diabetes mellitus or hypertension,
active vasculitis,
active malignancy other than basal-cell carcinoma,
HIV infection,
any clinically significant unstable medical condition as judged by the investigator.
Clareo Health | Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing
